KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Oscar Health (OSCR) Change in Receivables (2020 - 2025)

Historic Change in Receivables for Oscar Health (OSCR) over the last 6 years, with Q4 2025 value amounting to -$2.9 million.

  • Oscar Health's Change in Receivables fell 11767.14% to -$2.9 million in Q4 2025 from the same period last year, while for Dec 2025 it was $101.9 million, marking a year-over-year decrease of 1083.86%. This contributed to the annual value of $101.9 million for FY2025, which is 1083.86% down from last year.
  • Latest data reveals that Oscar Health reported Change in Receivables of -$2.9 million as of Q4 2025, which was down 11767.14% from -$20.0 million recorded in Q3 2025.
  • Oscar Health's 5-year Change in Receivables high stood at $164.2 million for Q1 2025, and its period low was -$98.0 million during Q3 2024.
  • For the 5-year period, Oscar Health's Change in Receivables averaged around $18.9 million, with its median value being $12.8 million (2021).
  • Within the past 5 years, the most significant YoY rise in Oscar Health's Change in Receivables was 74073.53% (2024), while the steepest drop was 70367.63% (2024).
  • Quarter analysis of 5 years shows Oscar Health's Change in Receivables stood at $14.7 million in 2021, then tumbled by 72.92% to $4.0 million in 2022, then soared by 170.12% to $10.8 million in 2023, then skyrocketed by 52.61% to $16.5 million in 2024, then crashed by 117.67% to -$2.9 million in 2025.
  • Its Change in Receivables stands at -$2.9 million for Q4 2025, versus -$20.0 million for Q3 2025 and -$39.4 million for Q2 2025.